Thermo Fisher Scientific Inc. Peer Comparison
| Metric | Value | Ranking | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $228.9 Billion | 1/10 | TMO $228.9B |
DHR $194.4B |
A $41.6B |
IDXX $39.1B |
MTD $31.0B |
ILMN $22.3B |
WAT $21.2B |
CRL $9.7B |
GH $2.6B |
NVTA $5.7M |
| Gross Margin | 41% | 8/10 | ILMN 65% |
IDXX 62% |
DHR 60% |
GH 59% |
WAT 58% |
MTD 58% |
A 56% |
TMO 41% |
CRL 33% |
NVTA 32% |
| Profit Margin | 15% | 6/10 | MTD 23% |
IDXX 20% |
WAT 20% |
A 18% |
DHR 16% |
TMO 15% |
CRL 9% |
GH -58% |
ILMN -100% |
NVTA -100% |
| EBITDA margin | 24% | 8/10 | ILMN 53% |
WAT 34% |
MTD 31% |
DHR 30% |
IDXX 26% |
A 25% |
CRL 25% |
TMO 24% |
GH -51% |
NVTA -808% |
| Quarterly Revenue | $10.5 Billion | 1/10 | TMO $10.5B |
DHR $5.7B |
A $1.6B |
ILMN $1.1B |
CRL $1.0B |
IDXX $1.0B |
MTD $946.8M |
WAT $708.5M |
GH $177.2M |
NVTA $121.2M |
| Quarterly Earnings | $1.5 Billion | 1/10 | TMO $1.5B |
DHR $907.0M |
A $282.0M |
MTD $221.8M |
IDXX $203.3M |
WAT $142.7M |
CRL $90.0M |
GH -$102.6M |
NVTA -$942.1M |
ILMN -$2.0B |
| Quarterly Free Cash Flow | $1.7 Billion | 1/10 | TMO $1.7B |
DHR $1.1B |
A $360.0M |
MTD $233.7M |
IDXX $215.0M |
CRL $154.0M |
ILMN $49.0M |
WAT $18.4M |
NVTA -$66.9M |
GH -$99.1M |
| Trailing 4 Quarters Revenue | $42.3 Billion | 1/10 | TMO $42.3B |
DHR $22.2B |
A $6.5B |
ILMN $4.4B |
CRL $4.1B |
IDXX $3.8B |
MTD $3.8B |
WAT $2.9B |
GH $643.8M |
NVTA $481.6M |
| Trailing 4 Quarters Earnings | $6.2 Billion | 1/10 | TMO $10.5B |
DHR $5.7B |
A $1.6B |
ILMN $1.1B |
CRL $1.0B |
IDXX $1.0B |
MTD $946.8M |
WAT $708.5M |
GH $177.2M |
NVTA $121.2M |
| Quarterly Earnings Growth | 14% | 2/10 | A 154% |
TMO 14% |
MTD 4% |
WAT -5% |
CRL -7% |
IDXX -9% |
DHR -18% |
GH -41% |
NVTA -213% |
ILMN -750% |
| Annual Earnings Growth | 19% | 3/10 | NVTA 82% |
A 39% |
TMO 19% |
CRL 6% |
WAT 4% |
MTD 1% |
IDXX -2% |
GH -4% |
DHR -23% |
ILMN -1253% |
| Quarterly Revenue Growth | -1% | 4/10 | DHR 42% |
GH 29% |
IDXX 6% |
TMO -1% |
CRL -3% |
WAT -4% |
MTD -4% |
ILMN -5% |
A -6% |
NVTA -9% |
| Annual Revenue Growth | -1% | 6/10 | GH 23% |
IDXX 4% |
WAT 3% |
ILMN 0% |
MTD 0% |
TMO -1% |
CRL -2% |
A -5% |
NVTA -11% |
DHR -13% |
| Cash On Hand | $7.1 Billion | 1/10 | TMO $7.1B |
DHR $2.4B |
A $1.8B |
GH $1.0B |
ILMN $920.0M |
IDXX $401.6M |
WAT $326.4M |
CRL $179.5M |
NVTA $158.0M |
MTD $70.8M |
| Short Term Debt | $5.1 Billion | 1/10 | TMO $5.1B |
DHR $1.9B |
ILMN $815.0M |
A $795.0M |
IDXX $420.1M |
MTD $311.2M |
GH $27.7M |
WAT $26.4M |
NVTA $21.6M |
CRL $3.2M |
| Long Term Debt | $30.3 Billion | 1/10 | TMO $30.3B |
DHR $16.3B |
CRL $2.4B |
A $2.1B |
WAT $2.0B |
MTD $1.7B |
ILMN $1.5B |
NVTA $1.5B |
GH $1.1B |
IDXX $524.7M |
| PE | 36.80 | 4/10 | DHR 46.26 |
IDXX 46.20 |
MTD 39.43 |
TMO 36.80 |
WAT 35.56 |
A 29.44 |
CRL 22.44 |
ILMN -1.00 |
NVTA -1.00 |
GH -1.00 |
| PS | 5.41 | 6/10 | IDXX 10.32 |
DHR 8.76 |
MTD 8.26 |
WAT 7.36 |
A 6.40 |
TMO 5.41 |
ILMN 5.04 |
GH 3.99 |
CRL 2.38 |
NVTA 0.01 |
| PB | 4.82 | 5/10 | IDXX 24.72 |
ILMN 15.53 |
WAT 15.00 |
A 7.05 |
TMO 4.82 |
DHR 3.90 |
CRL 2.57 |
MTD 0.00 |
NVTA 0.00 |
GH 0.00 |
| PC | 32.31 | 6/10 | MTD 437.52 |
IDXX 97.28 |
DHR 81.90 |
WAT 64.89 |
CRL 53.98 |
TMO 32.31 |
ILMN 24.24 |
A 23.39 |
GH 2.48 |
NVTA 0.04 |
| Liabilities to Equity | 1.07 | 5/10 | ILMN 3.23 |
WAT 2.15 |
IDXX 1.16 |
CRL 1.12 |
TMO 1.07 |
A 0.86 |
DHR 0.57 |
MTD 0.00 |
NVTA 0.00 |
GH 0.00 |
| ROA | 0.06 | 5/10 | IDXX 25% | MTD 24% | A 13% | WAT 13% | TMO 6% | DHR 5% | CRL 5% | GH -30% | ILMN -50% | NVTA -269% |
| ROE | 0.13 | 6/10 | GH 30425% |
NVTA 133% |
IDXX 54% |
WAT 42% |
A 24% |
TMO 13% |
CRL 12% |
DHR 8% |
ILMN -212% |
MTD -514% |
| Current Ratio | 1.93 | 3/10 | DHR 2.74 |
A 2.16 |
TMO 1.93 |
CRL 1.90 |
IDXX 1.86 |
WAT 1.46 |
ILMN 1.31 |
GH 1.00 |
MTD 0.96 |
NVTA 0.33 |
| Quick Ratio | 0.17 | 5/10 | DHR 46.26 |
IDXX 46.20 |
MTD 39.43 |
TMO 36.80 |
WAT 35.56 |
A 29.44 |
CRL 22.44 |
ILMN -1.00 |
NVTA -1.00 |
GH -1.00 |
| Long Term Debt to Equity | 0.64 | 3/10 | WAT} 1.42 |
ILMN} 1.04 |
TMO} 0.64 |
CRL} 0.64 |
A} 0.36 |
DHR} 0.33 |
IDXX} 0.33 |
NVTA} -1.37 |
MTD} -11.43 |
GH} -707.54 |
| Debt to Equity | 0.75 | 4/10 | ILMN 2.03 |
WAT 1.48 |
CRL 0.76 |
TMO 0.75 |
IDXX 0.60 |
A 0.50 |
DHR 0.36 |
NVTA -1.39 |
MTD -13.47 |
GH -831.44 |
| Burn Rate | 7.51 | 4/10 | A 797.76 |
CRL 29.36 |
DHR 10.76 |
TMO 7.51 |
GH 6.67 |
ILMN 0.41 |
NVTA 0.16 |
MTD -0.96 |
IDXX -5.20 |
WAT -5.84 |
| Cash to Cap | 0.03 | 5/10 | NVTA 27.58 |
GH 0.40 |
A 0.04 |
ILMN 0.04 |
TMO 0.03 |
WAT 0.02 |
CRL 0.02 |
DHR 0.01 |
IDXX 0.01 |
MTD 0.00 |
| CCR | 1.07 | 4/10 | CRL 1.71 |
A 1.28 |
DHR 1.25 |
TMO 1.07 |
IDXX 1.06 |
MTD 1.05 |
GH 0.97 |
WAT 0.13 |
NVTA 0.07 |
ILMN -0.02 |
| EV to EBITDA | 100.95 | 5/10 | IDXX} 150.15 |
DHR} 120.30 |
MTD} 111.21 |
A} 107.97 |
TMO} 100.95 |
WAT} 96.23 |
CRL} 48.31 |
ILMN} 41.26 |
NVTA} -1.38 |
GH} -31.98 |
| EV to Revenue | 6.07 | 6/10 | IDXX 10.47 |
DHR 9.48 |
MTD 8.79 |
WAT 7.98 |
A 6.58 |
TMO 6.07 |
ILMN 5.49 |
GH 4.47 |
CRL 3.03 |
NVTA 2.82 |